Philip Philip, MD of Karmanos Cancer Institute discusses the possible benefits of the use of immunotherapy in gastrointestinal diseases at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Is there a benefit to using immunotherapy in patients with gastric or gastroesophageal junction tumors?
